Chemotherapy, targeted therapy and immunotherapy: Which drugs can be safely used in the solid organ transplant recipients?-Reference-Cited by-同舟云学术

Chemotherapy, targeted therapy and immunotherapy: Which drugs can be safely used in the solid organ transplant recipients?

Published:2021-10-28 Issue:12 Volume:34 Page:2442-2458
ISSN:0934-0874
Container-title:Transplant International
language:en
Short-container-title:Transplant International

Author:

Maggiore Umberto¹²,Palmisano Alessandra²,Buti Sebastiano³,Claire Giudice Giulia³,Cattaneo Dario⁴,Giuliani Nicola¹⁵,Fiaccadori Enrico¹²,Gandolfini Ilaria¹²,Cravedi Paolo⁶

Affiliation:

1. Department of Medicine and Surgery University of Parma Parma Italy

2. Nephrology Unit University Hospital of Parma Parma Italy

3. Medical Oncology Unit University Hospital of Parma Parma Italy

4. Unit of Clinical Pharmacology ASST Fatebenefratelli Sacco University Hospital Milan Italy

5. Hematology Unit Azienda Ospedaliero‐Universitaria di Parma Parma Italy

6. Renal Division Department of Medicine Icahn School of Medicine at Mount Sinai New York NY USA

Publisher

Frontiers Media SA

Subject

Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tri.14115

Reference108 articles.

1. Cancer Mortality Among Recipients of Solid-Organ Transplantation in Ontario, Canada

2. Cancer and Mortality in Solid-Organ Transplantation: Preventable or Inevitable?

3. Survival after a cancer diagnosis among solid organ transplant recipients in the United States

4. Acute Kidney Injury in Patients with Cancer

5. Adjuvant Chemotherapy With Gemcitabine Plus Cisplatin for Kidney Transplant Patients With Locally Advanced Transitional Cell Carcinoma

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of long-term complications from immunosuppression;Liver Transplantation;2024-02-06

2. Hydrogen sulfide responsive nanoplatforms: novel gas responsive drug delivery carriers for biomedical applications;Asian Journal of Pharmaceutical Sciences;2023-10